FDA Inspection 1016857 — Nuvectra Corporation
The FDA completed an inspection of Nuvectra Corporation on April 12, 2017 in Blaine, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Blaine, MN (United States)
Additional Details
Postmarket Audit Inspections